4519 vs JCR: Side-by-Side Comparison
Compare Chugai Pharmaceutical Co., Ltd. (4519) and JCR Pharmaceuticals Co., Ltd. (JCR) side by side: market cap JPY 12.40T vs EUR 300.16M, P/E 28.6 vs 24.6. Financials, growth and model signals on Bullrun.
| Metric | 4519 | JCR |
|---|---|---|
| Company | Chugai Pharmaceutical Co., Ltd. | JCR Pharmaceuticals Co., Ltd. |
| Country / Exchange | Japan · TSE | Japan · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Market cap | JPY 12.40T | EUR 300.16M |
| P/E ratio | 28.6 | 24.6 |
| Dividend yield | 1.74% | 4.43% |
| Valuation model | — | 17.6% overvalued |
| Revenue (FY2025) | JPY 1.26T | EUR 33.07B |
| Revenue growth YoY | +7.5% | -22.9% |
| Net income | — | EUR -4.76B |
| Gross margin | 71.1% | 65.7% |
| Diluted EPS | 263.72 | -38.43 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.